Concepedia

Zhi‐Jie Ni

ZN

Statistics

Publications

36

Citations

1.8K

H-Index

27

Active since

1987

Affiliations

GlaxoSmithKline (United States)(Current)

Research Triangle Park Foundation

GlaxoSmithKline (United Kingdom)

Emory University

Affymax (United States)

Zhi‐Jie Ni is an author at GlaxoSmithKline (United States) specializing in chemistry, organic chemistry, and drug discovery.

Publications per year

1987–2021

36

Publications

36

Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer

Matthew T. Burger, Sabina Pecchi, Allan S. Wagman et al. · ACS Medicinal Chemistry Letters · 2011 · 251 citations · Full text

, , +13

Transition-Metal-Mediated C-S Bond Cleavage Reactions

Tien‐Yau Luh, Zhi‐Jie Ni · Synthesis · 1990 · 124 citations

, , +15

Versatile Approach To Encoding Combinatorial Organic Syntheses Using Chemically Robust Secondary Amine Tags

Zhi‐Jie Ni, Derek Maclean, Christopher P. Holmes et al. · Journal of Medicinal Chemistry · 1996 · 106 citations

, , +13

The discovery of tetrahydro-β-carbolines as inhibitors of the kinesin Eg5

Paul A. Barsanti, Weibo Wang, Zhi‐Jie Ni et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 98 citations · Full text

, , +8

Anti‐HCV therapies in chimeric scid‐Alb/uPA mice parallel outcomes in human clinical application†

Norman M. Kneteman, Amy J. Weiner, Juliette O’Connell et al. · Hepatology · 2006 · 98 citations · Full text

, , +17

1–5 of 36